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T cell help to the potential mimic epitopes. Some potential mimic epitopes in Zika virus 23 envelope have apparently strong T cell help, likely facilitating immunoglobulin class switch. We 24 also identify epitope mimic commonalities with dengue serotypes 1 and 3. We hypothesize that 25 antibodies to Zika virus epitopes may contribute to the pathogenesis of Zika-associated Barré syndrome, microcephaly, and ocular lesions, and may be a driver of autoimmunity. The 27 risk associated with responses to potential epitope mimics must be addressed in the development 28 of vaccines and therapeutics for Zika virus infections. 29
Introduction

38
Zika virus (ZIKV) has emerged as a rapidly spreading epidemic throughout the tropical 39
Americas. Known to cause mild febrile disease since its discovery in Uganda almost 70 years 40 ago [1] , changes in the clinical signs of Zika were noted following its appearance in French 41
Polynesia, and arrival in Latin America. Here, infection may be followed by Syndrome (GBS) [2] and adult infection is also associated with other sensory neurologic 43 impairment [3] . Spontaneous abortion and primary microcephaly, following infection during the 44 first 2 trimesters of pregnancy, is increasingly regarded as caused by ZIKV infection [4, 5] . 45
Ocular lesions have been noted in surviving infants [6, 7] . These and other neonatal neurologic 46 sequelae of infection during pregnancy constitute Zika fetal syndrome. GBS has been reported 47 sporadically following dengue infection [8, 9] , but is reportedly more severe in Zika case [10] . 48
The incidence of teratogenic lesions sets Zika apart from dengue. ZIKV has been detected by 49
Epitope analysis 86
Binding of viral peptides to B and T cells is a competitive process. To assess binding in the 87 competitive context of each protein, the polyprotein of each flavivirus was broken out into 88 individual proteins based on GenPept annotations to allow standardization of competitive 89 binding. Arrays of predicted major histocompatibility complex (MHC) binding, as well as of 90 linear B cell epitope probability were constructed for each sequential peptide in each of the 91 proteins. The applied mathematical tools used for the immunoinformatic analysis have been 92 previously described [16, 17] . Briefly, ensembles of neural network (NN) prediction equations 93 were developed using publically available databases of MHC class I and class II binding data 94 [18, 19] using the neural platform of the JMP® (SAS Institute, Cary, NC) statistical software 95 application. As initially described by Wold et al [20] , for multiple regression predictions the first 96 three principal components of amino acid physical properties were used as predictors in the input 97 layer of the neural networks. Ten ensembles are used for each allelic prediction. The use of 98 ensembles enables estimation of the mean binding affinity and an estimate of the variation in the 99 NN binding affinity prediction. All binding data generated by the NN were transformed to a 100 within-protein zero mean unit variance distribution using a Johnson Sb distribution algorithm in 101 JMP ® . This transformation puts all binding data on a common scale, making it possible to use 102 the principle of additivity of variance. 103
B cell epitope prediction 104
Viral proteins were analyzed to compute predicted probability of B cell epitopes (BEPIs), 105 standardized within protein. We had precomputed the proteome database to determine peptides 106 that fulfil the criteria of a potential BEPI within each source protein. We use a sliding 9-mer 107 window to compute predicted BEPIs, and for comparative purposes, the pentamer central core of 108 each predicted BEPIs was used to seek matches. A pentamer is chosen because, not only does it 109 provide a very stringent filter, but it corresponds to the area needed to engage the paratope of an 110 antibody [21] . A series of filters was applied to (a) find ZIKV protein pentamers with the highest 111 probability of functioning as BEPIs, this was initially set at the top 25%, and (b) identify 112 pentamers with the highest probability of being BEPIs in each of the >88,000 human proteins, 113 initially set at the top 40%. Matching BEPI pentamers were identified, then a third filter applied 114 (c) a search term of key words to extract human proteome proteins with neurologic functions. In 115 this case we utilized keywords comprising 56 variations on the terms "neur", "glial", "myelin", 116 "opt", and "synapt" ( Supporting Table S2 ). 117
Pentamers fulfilling all of these three criteria were declared to be potential Zika-proteome 118 epitope mimics. The stringency of these criteria can then be increased to identify the highest 119 probability mimics. This process provides a highly selective set of filters. Any single pentamer 120 has a 1 in 20 5 chance of occurrence (5 of 20 amino acids). When this probability is applied 121 independently to both the constituents of the Zika polyprotein and to the human proteome sets, 122 there is a 3423/20 5 x20 5 chance of a match, or 1 in 3.3x10 10 . This probability is further reduced by 123 application of the BEPI and keyword filters. However, the occurrence of multiple isoforms of 124 some proteins increases probability. In a further independent evaluation of the ZIKV proteins, 125 the adjacency to probable BEPIs of 15-mers with predicted high affinity MHC II binding was 126 determined, as these may stimulate specific T cell help. T cell help may stimulate a higher titer 127 of antibody, and will enable class switch to IgG. 128
The characteristics and performance of our B cell epitope (BEPI) prediction tools have likewise 129 been described elsewhere [22] . Briefly, like the MHC predictions, the BEPI prediction tools 130 comprise NN and use amino acid physical property principal components, and are aligned to the 131 BEPIPred [23] approach,. and developed to work within our data processing workflow. The 132 essential prediction is a probability that the central amino acid in a nonamer peptide resides 133 within a combinatorial "patch" of amino acids that might be a BEPI. The probability is 134 transformed to a within-protein zero mean unit variance distribution using a Johnson Sb 135 distribution. This process puts the metrics onto a common scale making it possible to use the 136 scaled metric as a statistical screening criterion that can be used on groups of proteins. For 137 convenience of comparison to standardized MHC binding where negative standardized scores 138 represent high affinity binding, the standardized BEPI probabilities are inverted (multiplied by -139 1). 140
Whereas MHC binding predictions lead to a specific binding affinity prediction for a particular 141 peptide, this cannot be done in the case of a B cell somatic hypermutational response in a 142 germinal center response to infection. The B cells will generate an enormous number of different 143 antibody molecules with differing affinities targeting the same "patch" of amino acids. 144
Moreover, as has been shown for the B cell repertoire responders to tetanus toxoid the population 145 of B cells surviving in the steady state may represent a small fraction of the early responding 146 population [24] . We have restricted the primary screen to the central pentamer of the nonamer in 147 the NN. A central pentamer can be found in different molecular contexts with different predicted 148 propensities for B cell interactions. Such a central pentamer can be found in 20 4 different 149 flanking tetramer contexts with different predicted propensities for B cell interactions. The 150
Pearson correlation (r = 0.44, P < 0.0001) measures the magnitude of the effect of the flanking 151 tetramers on overall BEPI probability (Supporting Figure S1 ). 152
During the analysis it became apparent that ZIKV pentamers with high BEPI probability were 153 also generating very high probability matches to von Willebrand's factor A (VWA). Because this 154 factor could be implicated in the clinical signs (hemorrhagic microvascular rash), this group of 155 pentamers was added to the subset for further analysis. 156
Thus, we predicted ZIKV BEPIs likely to give rise to anti-Zika antibodies, and to also 157 specifically react with BEPIs in target human proteins of neurologic or other selected functions. 158
This process was repeated with other ZIKV isolates, and the other selected flaviviruses. The 159 predicted Zika-proteome mimics identified by the screening process were evaluated to address 160 the following questions: How do epitope mimics in Zika Brazil differ from those predicted in 161 Zika Africa? Are potential mimics unique to Zika versus other flaviviruses? Do other 162 flaviviruses have mimics in the same human proteins? What fraction of the MHC alleles are 163 likely to provide help in generating antibodies targeting these mimics? 164
Structural Analysis 165
Envelope (E) protein structure models were predicted using NovaFold ® (DNASTAR, Inc., 166 version 13.0, structure template library 2015-W47-5). NovaFold ® , which is based on the I-167
TASSER structure prediction algorithm [25] [26] [27] , selects a collection of potential structure 168 templates using protein threading alignments, then perturbs the selected templates into lower-169 energy conformations using replica exchange simulations, and finally relaxes the backbone and 170 side chains of the final models using all-atom energetic refinement. The E protein ectodomain 171 sequences for Zika Brazil (GenBank: ALU33341.1) and Zika Africa (GenBank: AHL43504.1) 172 strains were obtained from the Zika virus polyprotein (residues 291-690). The top templates 173 included E protein structures from West Nile (PDB ID: 2I69) and Tick-borne encephalitis 174 viruses (PDB ID: 1SVB). Accuracy is estimated in terms of predicted Template Model score 175 (TM-score; a metric weighing close atom pairs between structures greater than more distant atom 176 pairs; closer to 1 is better, greater than 0.5 indicates a correct fold) [28, 29] . TM-score has been 177 proven to be a more robust metric than root mean square deviation (RMSD) as it is less sensitive 178 to local structural variations [30] . For the Brazil model, the predicted TM-score was 0.85; for the 179 Africa model, it was 0.87. Both scores are indicative of a high degree of confidence in the 180 accuracy of the predicted structures. 181
Surface patches of the Zika virion were modeled by aligning individual copies of the predicted E 182 protein models onto the cryo-electron microscopy structure of the dengue serotype 1 virus (PDB 183 ID: 4CCT, resolution 4.5 Å). The modeled virion patch consists of the following dengue E 184 proteins from the biological assembly: chains A, B, and C from model 1; chains A and C from 185 model 6; and chain B from model 10. Pairwise structure alignments were performed using TM-186 align [31] in Protean 3D™ (DNASTAR, Inc., version 13.0). Compared to the dengue E protein 187 structure, the TM-score was 0.77 for the Zika Brazil E protein model and 0.74 for the Africa 188 model. Solvent-accessible surfaces for the collective patch of six E proteins were calculated 189 using EDTsurf [32] in Protean 3D™. 190
Results
191
Envelope protein epitopes 192
As the structural proteins are exposed to the immune system and account for nearly all of the 193 antibodies elicited by comparable flaviviruses, we first examined the structural proteins, with 194 emphasis on the envelope protein [33, 34] . Despite substantial sequence differences in the 195 envelope proteins among the different viruses, there is a strong similarity in the molecular 196 location of predicted linear B cell epitopes ( Figure 1 ). Our in silico predictions of dengue linear 197 B cell epitopes are consistent with those mapped by monoclonal antibodies [35, 36] . Epitopes in 198 envelope domain II (EDII), conserved across other flaviviruses and thought to contribute to 199 antibody dependent enhancement (ADE) [37] , are also preserved in Zika virus. A band of 200 predicted high affinity MHC binding, located at amino acid positions 194-224 ( Figure 1 ), is 201 observed in all flavivirus envelopes examined. However, there is more difference in distribution 202 of other peptides with predicted high affinity MHC class I and II binding between the analyzed 203 flaviviruses. Of note in ZIKV is a region at amino acid positions 369-390, adjacent to the DE 204 loop of envelope domain III (EDIII), with high predicted MHC II binding across all HLA alleles. 205
Overall, the concordance between our in silico predictions and traditional experimental epitope 206 mapping in flaviviruses lends support to the approaches described below, and is consistent with 207 prior reports [22] . We also noted (data not shown) that compared to other viruses of similar size, 208 ZIKV has an overall very high degree of peptide motif match to the human proteome. 209 Collectively, all ZIKV proteins in the two isolates examined comprise 103 pentamers meeting 226 the criteria of predicted Zika-proteome epitope mimics laid out above. Of these, 88 were 227 conserved between Zika Africa and Zika Brazil, 15 distinct new ones were gained in Zika Brazil, 228 and 13 present in Zika Africa were lost before arrival in Brazil. Table 1 summarizes those in the 229 three structural proteins. Mimic matches for all proteins are listed in Supporting Table S3 . Figure  230 2 shows five potential mimics stand out as having the highest probability of generating a high 231 antibody titer. 232 Supporting Table S3 .
252
To examine the locations of the novel motifs identified by the predicted mimic pentamers, we 253 constructed an atomic (3D) model of the Zika Brazil and Zika Africa envelope protein (E 254 protein) using NovaFold ® structure prediction software from DNASTAR, Inc. NovaFold ® uses a 255 hybrid modeling approach that incorporates homologous structures and ab initio modeling to 256 accurately predict a protein's 3D structure from its amino acid sequence. As seen in Figure 3 
276
A high probability of a mimic to optineurin occurs in EDI (PRAEA). Structurally adjacent to 277 this, EDI also comprises two overlapping predicted pentamer mimic motifs, found in Zika Brazil 278 but not Zika Africa, with matches to neural navigator 2 (NAV2) (KGRLS) and to neural 279 development factor 4 (LSSGH). These predicted new mimics arise from a single SNP leading to 280 the F285S mutation, first detected in SE Asian isolates . 281
To further investigate the KGRLS epitope, we constructed a model of the Zika Brazil and Africa 282 E proteins in a mature virion configuration ( Figure 5 ) using Protean 3D™ molecular modeling 283 software from DNASTAR, Inc. Both Ser 285 (Brazil) and Phe 285 (Africa) are expected to be 284 solvent-accessible, but also reside in a cleft formed at the interface between two E protein 285 subunits. The F285S mutation suggests this cleft may be deeper and more polar in Zika Brazil, 286 altering the BEPIs exposed at this location. The virion models also suggest that, given their 287 relative spatial proximity, Thr 156 and Ser 285 in Brazil and Ile 156 and Phe 285 in Africa may 288 form conformational epitopes with differing geometric and chemical characteristics. A further 289 predicted new mimic (GGALN), for neurogenic locus notch homolog protein 1 (NOTC1), occurs 290 close to the C terminus of the soluble portion of the envelope, but is detected only at a low 291 stringency BEPI probability selection. 292 
295
The solvent-accessible surface is colored to distinguish the location of the individual E proteins.
296
Labeled residues on the central green subunit denote nonsynonymous variations between Zika 297 Brazil and Zika Africa. Additionally, the surface is colored bright pink for region associated with 298 position 285 (part of the KGRLS epitope) and light green for the remaining residues. Positions 299 156 and 285 are colored in the other subunits to establish the orientation relative to the central 300 subunit. Notably, Ser 285 (A) is predicted to be solvent exposed, but residing in a cleft formed 301 between two subunits.
303
Epitope mimics in other flavivirus envelope proteins 304
We compared epitopes of ZIKV and other flaviviruses, using an approach designed to identify 305 complex sharing patterns, to assess the differences in antibody mimics that each may generate. 306
Despite the taxonomic similarity there are few predicted mimics in common between ZIKV and 307 the other flaviviruses investigated. Only two of the pentamer predicted Zika mimics were found 308 to be identical to mimics predicted from other flaviviruses. AGADT, shared by Zika Brazil, Zika 309
Africa and dengue 4, does not fulfill the mimic criteria of BEPI probability in the proteome. 310 QPENL, shared by Zika Brazil, Zika Africa and with dengue type 2, only does so at the lowest 311 stringency. 312
The other flaviviruses do contain a small number of potential mimics, which could generate 313 antibodies that target the same human proteins as Zika antibodies, but through different pentamer 314 motifs. For the envelope protein, these are shown in Table 2 . Of particular interest are the human 315 proteins where ZIKV has a high probability mimic. Most lineages of dengue type 3 carry a 316 predicted mimic pentamer, GEDAP, which matches a pentamer in the mature NPY peptide. This 317 differs from ZIKV, where the conserved pentamer mimic, ESTEN, is in the CPON component of 318 the NPY propeptide [39], as shown in Figure 6 . The dengue type 3 GEDAP motif is present in 319 134 of 277 recent (since 2000) South American dengue type 3 isolates analyzed. These subtype 320 III isolates are from the Brazilian lineage. The remaining isolates, from the Venezuelan 321 sublineage [40] instead carry the motif GEDVP. GEDVP has no mimic matches with proteins of 322 neurologic function. GEDAP is conserved in all of 245 Asian dengue type 3 examined from the 323 same time period. The proNPY mimic peptide in ZIKV is in EDIII and is strongly associated 324 with predicted MHC II binding. In dengue type 3 GEDAP is located in EDIII at index position 325 322, a less exposed position, and adjacent peptides only have strong predicted binding affinity to 326 5 MHC II alleles. This implies there may be individual differences in antibody titer to this 327 dengue epitope. 328 Dengue type 1 carries two potential mimic pentamers for different locations in NAV2 (Figure 7) . 342 TPQAP is a low probability mimic due to its low BEPI score. TDKEK is in dengue type 1 EDIII 343 DE loop and is present in all of 146 South American and 1126 Asian dengue type 1 isolates 344 checked for the period 2000-2015. 345 Our analysis of dengue viruses was done with the intention of identifying mimicry similarities 346 and differences between dengue and ZIKV and included only a limited number of comparative 347 strains of dengue virus. We did not conduct an analysis to identify all potential relevant mimics 348 in dengue. In light of our findings, more in-depth analysis of these and other epitope mimics and 349 their potential role in GBS as a sequel to dengue is warranted. Nevertheless, the fact that dengue 350 type 3 and dengue type 1 also carry mimics on NPY and NAV2 respectively, suggests potential 351 for an additive or complementary role to that of ZIKV. Other predicted mimics for other human 352 proteins shared between ZIKV and other flaviviruses may have a combined impact. In each case 353 this is conditioned by BEPI probability, and by whether associated T cell help enhances antibody 354 titer. 355 
360
Other viruses 361
Preliminary analysis of chikungunya did not find potential neurologic protein mimics meeting 362 our criteria in proteins E1 or E2, and one very low probability NAV2 match in the capsid, 363 leading us to conclude that a cross-stimulation of Zika specific antibodies by this virus was 364 unlikely. Comparative analysis performed on CMV and rubella was confined to surface and 365 membrane proteins. This identified NAV2 matches in CMV membrane protein B and rubella E2. 366 No NPY matches were detected. 367
Discussion
368
Immunoinformatic analysis, such as that described here, has the advantage of rapidly bringing 369 together a large array of data and enabling pattern recognition, often unapparent at the bench or 370 in the field. It allows the development of hypotheses which must then be tested in vivo. In light 371 of the severity of the threat posed by ZIKV, and the speed at which the epidemic is apparently 372 expanding, there is an urgent need to develop medical countermeasures [41] . We therefore opted 373 to make these results available to the Zika community to allow them to be considered before 374 completion of field validation. This is currently limited by the biological time inherent in 375 production of stringent test reagents. 376
Our analysis leads to the hypothesis that antibodies to ZIKV may contribute to the pathogenesis 377 of the clinical outcomes, and indeed may be a primary driver of GBS, microcephaly, and the 378 ocular lesions seen in infants. This has critical implications for development of therapeutic and 379 prophylactic interventions. An antibody mediated effect may be independent of, or compound, 380 the impact of viral replication. 381
Generally, the occurrence of potential mimicry, as laid out here for ZIKV, is no different from 382 any other virus; all viruses carry pentamers which generate antibodies that react to varying 383 degrees with targets on the human proteome. Some bind to target proteins having a critical 384 function in a critical time interval; most do not. Secondly, BEPIs found in human proteins vary 385 somewhat between isoforms, creating a range of probabilities (Supporting Figure S1 ). Yet 386 another variable is the degree to which T cell help supports the generation of high antibody titers. 387 Thus, rather than a black and white/mimic versus not mimic, we are evaluating fuzzy logic, 388 driven by overlapping probabilities. What sets ZIKV apart is that it appears to have a particularly 389 problematic set of possible mimics. This includes the convergence of highly conserved potential 390 mimics in its EDIII PVITESTENSK sequence, where there is contextually adjacent robust T cell 391 help predicted. Added to this is the pair of newer high probability motifs in EDI which appeared 392 with the F285S mutation. 393
Neutralizing antibodies for dengue typically cross link domains or molecules and limit 394 movements of envelope proteins [34] . However, as evidenced by epitope mapping with peptides, 395 this does not preclude linear epitopes from generating antibodies, neutralizing or not [36] . We 396 would expect the same to be true for ZIKV. Coupling the amino acid sequence combinatorial 397 selection with stringent co-selection of high BEPI probability, plus physiological and clinical 398 criteria provides a very stringent and focused molecular identification process. This identifies a 399 relatively small set of potential targets with likely clinical relevance. Our structural analysis of 400 the consequences of the acquired mutations in the envelope identifies that the F285S mutation 401 changes the exposure of BEPIs, possibly also creating new conformational epitopes. The impact 402 of these mutations on the epitopes exposed in the immature virion, or their effect on constraining 403 envelope flexibility, have not yet been explored. 404
The proteins identified as the targets of antibodies to high probability ZIKV mimic epitopes, 405 including proNPY, NAV2, NDF4, NT4, BDNF, and neurexins, are proteins with diverse roles in 406 neurologic function and in embryonic development [39, [42] [43] [44] [45] [46] . Sorting out the possible relative 407 disruption of these in a ZIKV infection will be a complex challenge. We will only comment 408 briefly on those proteins corresponding to the highest probability mimics. 409 NPY has been widely studied and found in many CNS and peripheral nervous tissue 410 locations [47] . It is present very early in embryonic development [48] . Roles for NPY have been 411 described in maintaining retinal development and health [39] . NPY is recognized as an 412 immunomodulator with interactions with inflammation and immune response [49, 50] and is 413 protective against the neurovirulence of retroviral infection [51] . The role of the CPON 414 propeptide partner, where we predict anti-Zika antibodies would bind, is poorly understood, but 415 CPON is widely distributed and contributes to neural injury recovery [52, 53] . Whether antibody 416 binding would compromise propeptide processing is unknown, but is feasible. In an analogous 417 situation, antibodies to the propeptide of insulin are important contributors to diabetes [54] . NPY 418 is found in only one isoform in humans which, like insulin, may exacerbate the consequences of 419 reduced NPY availability. Interestingly, the ESTEN motif is present in proNPY of primates, but 420 variants occur in other species which may thus escape the effect of ZIKV mimics. 421
Optineurin, NAV2, and retinoic acid are part of the interactome necessary to retinal health and 422 fetal CNS development [55] [56] [57] . In particular, NAV2 has been linked to fetal neurite growth and 423 axonal extension [57] . Neural migration and extension are at a peak in the 13-21 weeks of 424 pregnancy [58] . 425
Antibodies binding to these proteins may compromise function or processing. In GBS, and other 426 sensory deficits, the effect may be a transient impairment of neurologic function, corresponding 427 to peak antibody titers. In a recent Zika report, a time line showed sensory impairment 428 paralleling the antibody titer [3] . Interruption of function of one or more of the proteins identified 429 during a critical stage of fetal development could lead to microcephaly and to the optic lesions 430 observed following maternal ZIKV infection in pregnancy. This may be the result of placental 431 transfer of maternal antibody, or endogenous fetal antibody, if fetal immune competence has 432 been attained. An autoimmune response driven by antibody is not mutually exclusive with 433 pathology arising from viral replication; both may occur. 434
Placental transfer of immunoglobulins to a fetus prior to blood brain barrier formation can be 435 detrimental to the fetus. The human placenta facilitates the transfer of IgG, but not IgM, 436 mediated by FcRn and increasing during the second trimester [59] . IgG1 and IgG4 are most 437 efficiently transferred. Approximately 10% of maternal IgG is thought to pass into the fetal 438 circulation, starting as early as week 13 [60] . The fetal blood brain barrier is not fully developed 439 until the third trimester and may preferentially transfer proteins to the fetal brain [61, 62] . Thus, 440 the literature suggests that the developing CNS is exposed to maternal antibodies in the first two 441 trimesters. There is precedent for autoimmune diseases caused by the transplacental passage of 442 antibody, including pemphigus, myasthenia gravis, and lupus [61, 63] . In dengue infection, 443 maternal antibodies transfer to the fetus, achieving a level determined by maternal antibody titer 444
[64]. Fetal anti-dengue titer may exceed maternal titer suggesting an active transfer process, 445 without direct adverse effects on the fetus being reported until ADE following post-natal dengue 446 infection [65] . A factor particularly enhancing placental transfer in the case of anti-Zika 447 antibodies to the pentamers in PVITESTENSK may be enhanced immunoglobulin class 448 switching to IgG, due to the adjacent MHCII binding peptides and T helper stimulation. 449
One of the vexing questions in Zika epidemiology has been why the observed pathology in the 450 New World differs from that in Africa. While ZIKV is confronting a new, immunologically 451 naïve population, the virus has also changed. As we show here the potential "mimicome" of 452 ZIKV has evolved with each mutation. While some pentamers, such as those in the 453 PVITESTENSK set, are conserved across all Zika isolates, others were more recently acquired. 454
Microcephaly has not been reported in Africa, but was reported following the Zika outbreak in 455
French Polynesia [66] . This follows the F285S mutation and associated predicted envelope 456 mimic addition. Whether GBS has been associated with ZIKV over the years is unclear, as it is 457 less conspicuous than microcephaly in an endemic setting, and especially in regions also 458 endemic for trypanosomiasis, malaria, and dengue. This begs the question of whether this is a 459 reporting phenomenon or whether some potential mimics may be more associated with GBS 460 (e.g. conserved NPY matches) than microcephaly. Unravelling such complex interactions will 461 take time. 462
The observation of high probability BEPIs, predicted to elicit antibodies to even higher 463 probability BEPIs in VWA is an interesting coincidental finding. The relevant pentamer motifs 464 are conserved between Zika Africa and Zika Brazil. The rash associated with ZIKV occurs after 465 peak viremia, coincident with the initial rise in antibodies. This association may be 466 multifactorial; antibody mimicry with other clotting factors has been noted in dengue [67] Polynesia was immediately preceded by reintroduction to the islands of dengue type 1 of SE 474
Asian origin, and dengue type 3 subtype III of South American origin, but unspecified 475 sublineage [2, 70] . Based on our findings, interactions with dengue could occur in two ways. As 476 generally predicted, ADE arising from the conserved region of the envelope protein and PrM 477 could exacerbate ZIKV infection. However, a further level of interaction may occur by the 478 "doubling up" of mimics, as exemplified by NPY and NAV2, at different locations in each, by 479 dengue 1 and dengue 3. Although there is overlap in the proteins targeted, the fact that anti-Zika 480 antibodies arise from an epitope having strong predicted T helper support, may lead to higher 481 titers and class switch than the antibodies from dengue epitopes with less T cell help. In this 482 preliminary analysis we have only begun to address the potential interactions with dengue. 483
Patterns of interaction with dengue may be particularly complex when multiple lineages co-484 circulate, some with and some without the NPY mimic [69] . A preliminary search of the 485 envelope (E1, E2) and capsid proteins of chikungunya virus did not identify any strong potential 486 mimics for the neurologically active proteins noted in ZIKV and dengue. 487
The pathology of microcephaly following Zika most closely resembles that observed in CMV 488 and rubella infection [71] . While in both these cases virus has been isolated from the affected 489 fetus and/or placenta, the exact pathway of pathogenesis is not understood [71, 72] . In CMV 490 higher levels of fetal antibody were observed in infants born with sequelae of infection [73] . Our 491 analysis of a small set of E1, E2, and capsid proteins of rubella, and the principal membrane 492 proteins of CMV identified pentamer matches to NAV2, a finding that begs further inquiry. 493
While a causal Zika-GBS-microcephaly relationship appears increasingly, likely but awaits 494 confirmation, the pathway laid out here provides a hypothesis for a mechanism of action and, 495 consequently, how such a mechanism could be tested. The prospect that the pathogenesis of 496 ZIKV may involve an antibody mediated autoimmune component must be addressed in vaccine 497 and therapeutic development. In assessing the consequences of both vaccination and natural 498 infection, it will be of particular importance to determine the duration of epitope-specific 499 responses, as well as which epitope-specific responses are induced as an anamnestic response on 500 re-exposure to the virus. Better understanding of epitope mimics may offer a specific pathway to 501 corresponding to the identical pentamer in the Zika virus 771 Table S1 : Viruses analyzed 772 Table S2: Keywords  773  Table S3 : 
